
384: Live from the JP Morgan conference, a sit-down with Novo Nordisk's CEO and VC Bob Nelsen
The Readout Loud
00:00
M&A strategy and patient-first approach
Mike outlines Novo's acquisition criteria focused on patient need and where they deploy capital.
Play episode from 15:45
Transcript


